Journal article
NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand
W Bukhari, E Khalilidehkordi, DF Mason, MH Barnett, BV Taylor, M Fabis-Pedrini, AG Kermode, S Subramanian, P Waters, SA Broadley, W Bukhari, SA Broadley, D Abernethy, S Bhuta, S Blum, M Boggild, K Boundy, BJ Brew, F Brilot, WJ Brownlee Show all
Journal of Neurology | SPRINGER HEIDELBERG | Published : 2022
Abstract
Background: We studied the prevalence of neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) in Indigenous populations of Australia and New Zealand with the aim of assessing potential differences. Methods: Cases of possible NMOSD and MS were collected from Australia and New Zealand. Clinical details, MR imaging, and serologic results were used to apply 2015 IPND diagnostic criteria for NMOSD and 2010 McDonald criteria for MS. Frequencies of self-determined ethnic ancestry were calculated for confirmed NMOSD, suspected NMOSD, and MS. Prevalence rates for NMOSD and MS according to ancestry were compared. Results: There were 75 cases with NMOSD, 89 with suspected NMSOD, a..
View full abstractGrants
Awarded by Abbott Laboratories
Funding Acknowledgements
Multiple Sclerosis Research Australia; Brain Foundation; Griffith University/Gold Coast Hospital Foundation; Contributing to Australian Scholarship and Science; NHS National Specialised Commissioning Group for NMO; NIHR Oxford Biomedical Research Centre.